TABLE 6.
Effects of Clostridium butyricum treatment on ileal bile acids (BAs)1 contents of laying hens.
| Control | Treatment | P-value | |
| Primary BAs (nmol/g) | |||
| TαMCA | 31.0111.88a | 17.586.24b | 0.015 |
| TβMCA | 3.681.58 | 2.961.64 | 0.426 |
| GCA | 0.730.43 | 1.070.47 | 0.153 |
| αMCA | 5.244.64 | 5.443.66 | 0.926 |
| βMCA | 0.390.12 | 0.380.20 | 0.933 |
| CDCA | 4520.76821.24 | 4836.781022.99 | 0.456 |
| CA | 496.84215.04 | 498.89255.05 | 0.986 |
| GCDCA | 4.331.73 | 6.652.90 | 0.072 |
| TCDCA | 3065.881571.45 | 3923.872476.42 | 0.454 |
| Secondary BAs (nmol/g) | |||
| TUDCA | 0.690.44b | 2.672.52a | 0.046 |
| THDCA | 1.210.84 | 0.570.31 | 0.065 |
| UCA | 0.660.34 | 0.700.62 | 0.885 |
| UDCA | 5.001.81 | 4.362.48 | 0.555 |
| 7-KDCA | 0.390.16 | 0.660.45 | 0.130 |
| 12-DHCA | 3.610.99 | 4.112.16 | 0.568 |
| λMCA | 57.0342.35 | 45.7124.76 | 0.553 |
| 3-DHCA | 1.270.52 | 1.880.92 | 0.122 |
| LCA | 0.310.12b | 0.650.33a | 0.016 |
| 7-KLCA | 9.852.09b | 17.467.32a | 0.009 |
| 12-KLCA | 0.310.16 | 0.400.15 | 0.273 |
| DCA | 0.560.22 | 0.580.13 | 0.763 |
| ApCA | 9.603.21 | 8.543.33 | 0.502 |
| AlCA | 127.8239.25 | 114.4142.87 | 0.499 |
| HDCA | 0.810.37 | 1.170.37 | 0.056 |
| TLCA | 0.670.40 | 0.860.38 | 0.366 |
a,bValues with different superscripts within the same row differ significantly (P < 0.05). 1TαMCA, tauro-α-muricholic acid; TβMCA, tauro-β-muricholic acid; GCA, glycocholic acid; αMCA, α-muricholic acid; βMCA, β-muricholic acid; CDCA, chenodeoxycholic acid; CA, cholic acid; GCDCA, glycochenodeoxycholic acid; TCDCA, taurochenodeoxycholic acid; TUDCA, tauroursodeoxycholic acid; THDCA, taurohyodeoxycholic acid; UCA, ursocholic acid; UDCA, ursodeoxycholic acid; 7-KDCA, 7-ketodeoxycholic acid; 12-DHCA, 12-dehydrocholic acid; λMCA, λ-muricholic acid; 3-DHCA, 3-dehydrocholic acid; LCA, lithocholic acid; 7-KLCA, 7-ketolithocholic acid; 12-KLCA, 12-ketolithocholic acid; DCA, deoxycholic acid; ApCA, apocholic acid; AlCA, allocholic acid; HDCA, hyodeoxycholic acid; TLCA, taurolithocholic acid.